Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Scientists at China Pharmaceutical University discuss research in cancer gene therapy
March 10th, 2009
"The survivin gene may be a good target for cancer gene therapy because it is overexpressed in a variety of human tumors, including gastric cancer, bill not in differentiated adult tissues. To explore effects of the siRNA of the survivin gene inducing apoptosis ill human gastric cancer cells, three siRNAs, cpusiRNA1, cpusiRNA2, and cpusiRNA3, were designed and transferred into human gastric carcinoma cell line SGC-823 (SGC-823)," researchers in Nanjing, People's Republic of China report. "The opposite livability oil SGC-823 cells was assayed with an MTT test. The change of mRNA and protein of survivin and p53 gene were detected by reverse-transcriptase polymerase chain...
Source: Cancer Weekly (2009-03-10)
|
